FOXM1: From cancer initiation to progression and treatment

被引:332
|
作者
Koo, Chuay-Yeng [1 ]
Muir, Kyle W. [1 ]
Lam, Eric W. -F. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London W12 0NN, England
关键词
FOXM1; Chemotherapy; Cancer; Function; Regulation; M1 TRANSCRIPTION FACTOR; BREAST-CANCER; CELL-PROLIFERATION; OXIDATIVE STRESS; UP-REGULATION; HEPATOCELLULAR CARCINOMAS; NUCLEAR TRANSLOCATION; MULTIDRUG-RESISTANCE; DOWNSTREAM TARGET; HEPATOCYTE ENTRY;
D O I
10.1016/j.bbagrm.2011.09.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Forkhead box protein M1 (FOXM1) transcription factor is a regulator of myriad biological processes, including cell proliferation, cell cycle progression, cell differentiation, DNA damage repair, tissue homeostasis, angiogenesis and apoptosis. Elevated FOXM1 expression is found in cancers of the liver, prostate, brain, breast, lung, colon, pancreas, skin, cervix, ovary, mouth, blood and nervous system, suggesting it has an integral role in tumorigenesis. Recent research findings also place FOXM1 at the centre of cancer progression and drug sensitivity. In this review the involvement of FOXM1 in various aspects of cancer, in particular its role and regulation within the context of cancer initiation, progression, and cancer drug response, will be summarised and discussed. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:28 / 37
页数:10
相关论文
共 50 条
  • [1] FoxM1 is overexpressed in human hepatocellular cancer and associated with cancer progression
    Wu, Qifei
    Liu, Chang
    Yu, Min
    Liu, Dong
    Tai, Min Hui
    Tian, Min
    Lv, Yi
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 211 (03) : S125 - S125
  • [2] Targeting FOXM1 in cancer
    Halasi, Marianna
    Gartel, Andrei L.
    BIOCHEMICAL PHARMACOLOGY, 2013, 85 (05) : 644 - 652
  • [3] Overexpressed transcription factor FOXM1 contributes to the progression of colorectal cancer
    Zhang, Hongmei
    Zhong, Hua
    Li, Lei
    Ji, Wansheng
    Zhang, Xiaoqian
    MOLECULAR MEDICINE REPORTS, 2016, 13 (03) : 2696 - 2700
  • [4] FOXM1 functions collaboratively with PLAU to promote gastric cancer progression
    Ai, Chao
    Zhang, Jixin
    Lian, Shenyi
    Ma, Jie
    Gyorffy, Balazs
    Qian, Zhenyuan
    Han, Yong
    Feng, Qin
    JOURNAL OF CANCER, 2020, 11 (04): : 788 - 794
  • [5] Dysregulated Expression of FOXM1 Isoforms Drives Progression of Pancreatic Cancer
    Kong, Xiangyu
    Li, Lei
    Li, Zhaoshen
    Le, Xiangdong
    Huang, Chen
    Jia, Zhiliang
    Cui, Jiujie
    Huang, Suyun
    Wang, Liwei
    Xie, Keping
    CANCER RESEARCH, 2013, 73 (13) : 3987 - 3996
  • [6] Role of FoxM1 in the Progression and Epithelial to Mesenchymal Transition of Gastrointestinal Cancer
    Zhang, Jing
    Niu, Yangyang
    Huang, Chen
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2017, 12 (03) : 247 - 259
  • [7] OVEREXPRESSION OF FOXM1 IS ASSOCIATED WITH TUMOR PROGRESSION
    Xue, Yijun
    Zhang, Guoxi
    Xu, Ruiquan
    Zou, Xiaofeng
    Zhong, Xin
    Wu, Gengqing
    Wang, Xiaoning
    Long, Dazhi
    Wu, Yuting
    Xu, Hui
    Liu, Min
    JOURNAL OF UROLOGY, 2013, 189 (04): : E783 - E783
  • [8] FoxM1 is a promising candidate target in the treatment of breast cancer
    Lu, Xiao-Feng
    Zeng, De
    Liang, Wei-Quan
    Chen, Chun-Fa
    Sun, Shu-Ming
    Lin, Hao-Yu
    ONCOTARGET, 2018, 9 (01) : 842 - 852
  • [9] The Promise of Combination Therapies with FOXM1 Inhibitors for Cancer Treatment
    Merjaneh, Nawal
    Hajjar, Mona
    Lan, Ying-Wei
    Kalinichenko, Vladimir V.
    Kalin, Tanya V.
    CANCERS, 2024, 16 (04)
  • [10] FOXM1: The Achilles' heel of cancer?
    Senthil K. Radhakrishnan
    Andrei L. Gartel
    Nature Reviews Cancer, 2008, 8 (3) : 242 - 242